» Authors » Amir H Zamanipoor Najafabadi

Amir H Zamanipoor Najafabadi

Explore the profile of Amir H Zamanipoor Najafabadi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 572
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Millward C, Keshwara S, Armstrong T, Barrington H, Bell S, Brodbelt A, et al.
Neurooncol Adv . 2024 Apr; 6(1):vdae030. PMID: 38596717
Background: Meningioma clinical trials have assessed interventions including surgery, radiotherapy, and pharmacotherapy. However, agreement does not exist on what, how, and when outcomes of interest should be measured. To do...
2.
Millward C, Islim A, Armstrong T, Barrington H, Bell S, Brodbelt A, et al.
Neurooncol Adv . 2024 Apr; 6(1):vdae042. PMID: 38596715
Background: The clinical management of patients with incidental intracranial meningioma varies markedly and is often based on clinician choice and observational data. Heterogeneous outcome measurement has likely hampered knowledge progress...
3.
Zamanipoor Najafabadi A, Dirven L, Drummond K, Taphoorn M
Adv Exp Med Biol . 2023 Jul; 1416:235-252. PMID: 37432632
Historically, largely due to the good prognosis for survival, there has been little attention paid to the possible impact of meningiomas and their treatment on health-related quality of life (HRQoL)....
4.
Quach K, Dirven L, Vingerhoed A, de Bresser J, Dammers R, Bos E, et al.
Neurooncol Adv . 2023 Jun; 5(1):vdad056. PMID: 37293257
Background: Fatigue is a commonly reported and severe symptom in primary brain tumor patients, but the exact occurrence in meningioma patients is unknown. This study aimed to determine the frequency...
5.
Koning A, Satoer D, Vinkers C, Zamanipoor Najafabadi A, Biermasz N, Nandoe Tewarie R, et al.
BMJ Open . 2023 Apr; 11(12):e054405. PMID: 37057711
Introduction: The synthetic glucocorticoid dexamethasone can induce serious neuropsychiatric adverse effects. Dexamethasone activates the glucocorticoid receptor (GR) but, unlike endogenous cortisol, not the mineralocorticoid receptor (MR). Moreover, dexamethasone suppresses cortisol...
6.
Huynh K, Coopmans E, Zamanipoor Najafabadi A, Dirven L, Peerdeman S, Biermasz N, et al.
J Neurooncol . 2023 Feb; 161(2):371. PMID: 36780104
No abstract available.
7.
Huynh K, Coopmans E, Zamanipoor Najafabadi A, Dirven L, Peerdeman S, Biermasz N, et al.
J Neurooncol . 2023 Jan; 161(2):357-370. PMID: 36626042
Purpose: Few studies have reported on healthcare utilization and costs for intracranial meningioma patients, while the tumor and its treatment profoundly affect patients' functioning and well-being. Here we evaluated healthcare...
8.
Zamanipoor Najafabadi A, van der Meulen M, Priego Zurita A, Ahmed S, van Furth W, Charmandari E, et al.
Endocr Connect . 2022 Nov; 12(1). PMID: 36327151
Objective: The European Reference Network on Rare Endocrine Conditions (Endo-ERN) aims to organize high-quality healthcare throughout Europe, including care for pituitary adenoma patients. As surgery is the mainstay of treatment,...
9.
George A, Gupta S, Keshwara S, Mustafa M, Gillespie C, Richardson G, et al.
Br J Neurosurg . 2022 Oct; 36(6):678-685. PMID: 36263847
Introduction: Systematic reviews (SR) and systematic reviews with meta-analysis (SRMA) can constitute the highest level of research evidence. Such evidence syntheses are relied upon heavily to inform the clinical knowledge...
10.
Al-Nofal M, de Boer I, Agirman S, Wilms A, Zamanipoor Najafabadi A, Terwindt G, et al.
Front Neurol . 2022 Sep; 13:989536. PMID: 36090874
Background: The brain and retina share many neuronal and vasculature characteristics. We investigated the retinal microvasculature in patients with a monogenic vasculopathy using optical coherence tomography angiography (OCTA). OCT-A is...